Profile: Impeto Medical specializes in medical devices for non-invasive assessment of eccrine sweat gland activity. EZSCAN™ is a device for screening and assessment of diabetes risk. It is used in non-invasive procedure for fast testing (2 minutes) where results are immediately available. It uses reverse iontophoresis and proprietary technology to measure the impact of early diabetes on the eccrine sweat gland system. It reliably detects deviations in the ionic balance of the sweat ducts caused by reduced innervation of eccrine sweat glands. This information is then used to determine the patient risk for pre-diabetes (IGT), diabetes and complications. SUDOSCAN+™ is an innovative device for diagnosis of diabetic neuropathy. It measures electrochemical sweat conductance which reflects sweat function which is sympathetic dependant.

FDA Registration Number: 3008496197
US Agent: Philippe Brunswick
Phone: +1-(858)-450-2800  Fax: +1-(858)-450-2804  E-Mail: